Role of serum and urine transforming growth factor beta 1, matrix metallopeptidase 9, tissue inhibitor of metalloproteinase 2, and nerve growth factor beta levels and serum neutrophil-to-lymphocyte ratio in predicting recurrence and progression risks in patients with primary non-muscle invasive bladder cancer.
Turkish journal of urology, vol.46, pp.206-212, 2020 (Peer-Reviewed Journal)
Article / Article
Turkish journal of urology
Emerging Sources Citation Index, Scopus, TR DİZİN (ULAKBİM)
Bladder cancer, MMP-9, NGF-beta, neutrophil-to-lymphocyte ratio, TGF-beta 1, TIMP-2, TRANSITIONAL-CELL CARCINOMA, EXPRESSION, RECEPTORS
Objective: The current study aimed to examine the correlation between serum and urine transforming growth factor beta 1 (TGF-beta 1), matrix metallopeptidase 9 ( MMP-9), tissue inhibitor of metalloproteinase 2 (TIMP-2), and nerve growth factor beta (NGF-beta) levels and serum neutrophil-to-lymphocyte ratio (NLR) as well as the recurrence and progression risks of non-muscle invasive bladder cancer (NMIBC).